{"id":236155,"date":"2021-03-15T14:16:56","date_gmt":"2021-03-15T18:16:56","guid":{"rendered":"https:\/\/oncubanews.com\/en\/?p=236155"},"modified":"2021-03-15T14:16:56","modified_gmt":"2021-03-15T18:16:56","slug":"loss-of-smell-good-prognosis-in-patients-with-covid-19","status":"publish","type":"post","link":"https:\/\/oncubanews.com\/en\/coronavirus\/loss-of-smell-good-prognosis-in-patients-with-covid-19\/","title":{"rendered":"Loss of smell, good prognosis in patients with COVID-19"},"content":{"rendered":"

Loss of smell is not only one of the factors for early diagnosis of <\/span>COVID-19<\/span><\/a>, but it is also a symptom of a good prognosis of the disease, according to an international research led by scientists from the Complutense University and the San Carlos Clinical Hospital, from Madrid.<\/span><\/p>\n

Through the study, carried out in numerous centers, with the largest sample used so far (5,868 hospitalized patients), the researchers have confirmed that although its origin is still a mystery, anosmia\u2014loss of smell\u2014can act as a good prognostic factor of the disease.<\/span><\/p>\n

\u201cThese results have many implications, from the initial evaluation of patients to the ability to understand the pathophysiology. Possibly, the invasion of the nasal epithelium causes an adequate immunity to be activated avoiding cytokine storms,\u201d explained Jes\u00fas Porta-Etessam, head of the Neurology Section of the San Carlos Clinical Hospital, professor at the Faculty of Medicine of the UCM and principal author of the work.<\/span><\/p>\n

In addition to identifying anosmia as a good prognostic factor, researchers have determined that olfactory and taste dysfunctions are more frequent in women (12.41% vs. 8.67%), in people under 65 years of age and in patients with kidney, lung, heart, neurological or oncological disorders.<\/span><\/p>\n

Piden reconocer la p\u00e9rdida de olfato como s\u00edntoma clave de la COVID-19<\/a><\/p><\/blockquote>\n